Neel Belani, MD

"My goal is to make your first visit—and every visit after—clear, supportive, and focused on you. I am a medical oncologist and hematologist with a special interest in thoracic malignancies, including non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). I have previously been involved in numerous novel clinical trials, including early-phase (Phase I/II) studies, evaluating emerging therapies for lung cancer and frequently attend oncology conferences and educational seminars to stay up-to-date. In addition, I have published research on multiple topics related to lung cancer. I feel confident applying the most advanced medical research to offer patients the best available options.

I believe great communication is essential to optimal care. I take the time to answer all of your questions and explain your diagnosis, scans, and treatment choices on a level you can understand—with patience, compassion, and reassurance. I emphasize biomarker testing and next-generation sequencing (NGS) to help personalize treatment, including targeted therapy and immunotherapy for lung cancer. I have particular experience treating biomarker-driven lung cancers with EGFR, ALK, MET exon 14, RET, KRAS, HER2, ROS1, MTAP and BRAF alterations.

I also place special emphasis on helping patients identify clinical trials, because clinical trials can often offer options that are more targeted than standard therapies. My goal is to deliver personalized treatment and guide you through every phase of care so you feel supported and confident in the plan. Having grown up in Central New Jersey, it is especially meaningful to provide warm, cutting-edge care to the community I call home."